MMedication Read More Regeneron (REGN) Says EMA Accepted Review for Otarmeni ApplicationJune 7, 2026 Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the 10 Best Debt-Free S&P 500 Stocks to Buy Now. On…